PainReform

$4.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.24 (+5.67%) Today
+$0.22 (+4.92%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can buy or sell PainReform and other stocks, options, and ETFs commission-free!

About PRFX

PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel. The listed name for PRFX is PainReform Ltd. Ordinary Shares.

CEO
Ilan Hadar
Employees
—
Headquarters
Herzliya, Tel Aviv
Founded
2007
Market Cap
40.59M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
65.74K
High Today
$4.65
Low Today
$4.16
Open Price
$4.19
Volume
155.94K
52 Week High
$7.85
52 Week Low
$3.82

Collections

PRFX Earnings

Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 8, Pre-Market

You May Also Like

PCG-C
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure